APP and Alzheimer disease: Further work investigating the effect of NSC-EVs discovered their role in ameliorating inflammation in the transgenic amyloid precursor protein (APP)/presenilin 1 (PS1) mouse model of Alzheimer’s disease (AD; Li et al., 2020).